4//SEC Filing
Levin Andrew David 4
Accession 0001867539-25-000006
CIK 0001817229other
Filed
Dec 18, 7:00 PM ET
Accepted
Dec 19, 6:14 PM ET
Size
6.1 KB
Accession
0001867539-25-000006
Insider Transaction Report
Form 4
Levin Andrew David
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-12-18+3,000→ 3,000 totalExercise: $12.80Exp: 2035-12-17→ Common Stock (3,000 underlying)
Footnotes (2)
- [F1]The shares shall vest and become exercisable in a series of 36 successive equal monthly installments beginning on December 18, 2025, in each case subject to the Reporting Person's continued service as of each such date.
- [F2]Under the Reporting Person's arrangement with RA Capital Management, L.P. (the "Adviser"), the Reporting Person holds the option for the benefit of the RA Capital Healthcare Fund, L.P. (the "Fund"). The Reporting Person is obligated to turn over to the Adviser any net cash or stock received from the option, which will offset advisory fees owed by the Fund to the Adviser. The Reporting Person therefore disclaims beneficial ownership of the option and underlying common stock.
Documents
Issuer
Vor Biopharma Inc.
CIK 0001817229
Entity typeother
Related Parties
1- filerCIK 0001867539
Filing Metadata
- Form type
- 4
- Filed
- Dec 18, 7:00 PM ET
- Accepted
- Dec 19, 6:14 PM ET
- Size
- 6.1 KB